Cargando…
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
BACKGROUND/AIMS: It is unknown whether different β-blockers (BBs) have variable effects on long-term survival of patients with heart failure with reduced ejection fraction (HFrEF). This study compares the effects of two BBs, carvedilol and bisoprolol, on survival in patients with HFrEF. METHODS: The...
Autores principales: | Choi, Ki Hong, Lee, Ga Yeon, Choi, Jin-Oh, Jeon, Eun-Seok, Lee, Hae-Young, Lee, Sang Eun, Kim, Jae-Joong, Chae, Shung Chull, Baek, Sang Hong, Kang, Seok-Min, Choi, Dong-Ju, Yoo, Byung-Su, Kim, Kye Hun, Cho, Myeong-Chan, Park, Hyun-Young, Oh, Byung-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718755/ https://www.ncbi.nlm.nih.gov/pubmed/30317846 http://dx.doi.org/10.3904/kjim.2018.009 |
Ejemplares similares
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
por: Choi, Ki Hong, et al.
Publicado: (2018) -
Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022) -
β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019) -
Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
por: Oh, Gyu Chul, et al.
Publicado: (2022) -
Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the Korean Acute Heart Failure (KorAHF) Registry
por: Oh, Jaewon, et al.
Publicado: (2019)